Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States
Open Access
- 1 January 1995
- Vol. 13 (17) , 1631-1635
- https://doi.org/10.1016/0264-410x(95)00137-p
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old childrenThe Pediatric Infectious Disease Journal, 1994
- Primum non nocereThe Pediatric Infectious Disease Journal, 1993
- Acellular Pertussis Vaccines--A Solution to the Pertussis ProblemThe Journal of Infectious Diseases, 1993
- Acellular Pertussis Vaccines—A Solution to the Pertussis Problem?The Journal of Infectious Diseases, 1993
- Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccinesThe Journal of Pediatrics, 1992
- Acellular Pertussis Vaccines: Recommendations for Use as the Fourth and Fifth DosesPublished by American Academy of Pediatrics (AAP) ,1992
- Efficacy of Whole-Cell Pertussis Vaccine in Preschool Children in the United StatesJAMA, 1992
- Pertussis: the trials and tribulations of old and new pertussis vaccinesVaccine, 1992
- Report of the Task Force on Pertussis and Pertussis Immunization—1988Pediatrics, 1988
- Statistical considerations in the quantitation of serum immunoglobulin levels using the Enzyme-Linked Immunosorbent Assay (ELISA)Journal of Immunological Methods, 1987